The following is an article Titled, "Where's My Adderall? Stubborn Drug Shortage Spurs Federal Inquiry, As Founders FretFor entrepreneurs who rely on ADHD medication--brand-name and generic alike--to help them focus, supply chain shortages and rising prices could negatively impact their ability to perform."
It gives a link to where you can make a comment to the regulations about this topic.
Regulations.gov site: https://www.regulations.gov/docket/FTC-2024-0018
As the country's shortage of prescription drugs drags on, the federal government is looking for answers. Specifically: Where are all the (typically) less-expensive generics--from cancer medications to Adderall-like stimulants for attention-deficit/hyperactivity disorder (ADHD)?
The Federal Trade Commission (FTC) and the U.S. Department of Health and Human Services (HSS) on Wednesday sent a joint request to pharmaceutical companies and group purchasing organizations, or GPOs, in an effort to get to the bottom of the shortages.
The following is an article Titled, "Where's My Adderall? Stubborn Drug Shortage Spurs Federal Inquiry, As Founders FretFor entrepreneurs who rely on ADHD medication--brand-name and generic alike--to help them focus, supply chain shortages and rising prices could negatively impact their ability to perform."
It gives a link to where you can make a comment to the regulations about this topic.